药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
19-Nor-4-androstenedione
Rufloxacin
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Rufloxacin.
19-Nor-4-androstenedione
Lidoflazine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Lidoflazine.
19-Nor-4-androstenedione
Piromidic acid
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Piromidic acid.
19-Nor-4-androstenedione
Acetyldigoxin
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Acetyldigoxin.
19-Nor-4-androstenedione
Lorajmine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Lorajmine.
19-Nor-4-androstenedione
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Oxolinic acid.
19-Nor-4-androstenedione
Prajmaline
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Prajmaline.
19-Nor-4-androstenedione
Bencyclane
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Bencyclane.
19-Nor-4-androstenedione
Cibenzoline
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Cibenzoline.
19-Nor-4-androstenedione
Gallopamil
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Gallopamil.
19-Nor-4-androstenedione
Cicletanine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Cicletanine.
19-Nor-4-androstenedione
Pilsicainide
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Pilsicainide.
19-Nor-4-androstenedione
Givinostat
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Givinostat.
19-Nor-4-androstenedione
Triclabendazole
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Triclabendazole.
19-Nor-4-androstenedione
Temefos
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Temefos.
19-Nor-4-androstenedione
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Tetrahydropalmatine.
19-Nor-4-androstenedione
Delafloxacin
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Delafloxacin.
19-Nor-4-androstenedione
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Prulifloxacin.
19-Nor-4-androstenedione
CUDC-907
The risk or severity of QTc prolongation can be increased when Bilastine is combined with CUDC-907.
19-Nor-4-androstenedione
Anisodamine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Anisodamine.